Literature DB >> 28397130

Antidiarrheal Drug Therapy.

Lawrence R Schiller1,2.   

Abstract

INTRODUCTION: Acute diarrhea often runs a self-limited course and little by way of treatment is needed except for oral rehydration therapy. Chronic diarrhea poses a longer-term problem. If not treatable with specific therapy aimed at the underlying pathophysiology, chronic diarrhea often needs long-term symptomatic therapy. PURPOSE OF REVIEW: This paper aims to examine the options for symptomatic, nonspecific treatment of diarrhea. RECENT
FINDINGS: The most frequently used therapies are opiate antidiarrheal drugs. These drugs are effective for a wide variety of diarrheal conditions and generally can be used safely if monitored closely. They work by slowing motility and allowing more time for absorption. They vary in potency and in addictive liability. In recent years, a variety of other drugs have been developed, which provide more targeted therapy that can mitigate diarrhea in specific situations. These drugs work on other regulatory pathways in the gut or on mucosal absorptive mechanisms. There is evidence for efficacy for both traditional and newer agents used for the symptomatic management of diarrhea. Opiates are used most often for this indication. Other agents may benefit individuals, but further research is needed to establish indications and best practices.

Entities:  

Keywords:  Acute diarrhea; Antidiarrheal drug; Chronic diarrhea; Gastrointestinal disorders

Mesh:

Substances:

Year:  2017        PMID: 28397130     DOI: 10.1007/s11894-017-0557-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  75 in total

Review 1.  Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis.

Authors:  Hoonmo L Koo; Diana C Koo; Daniel M Musher; Herbert L DuPont
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

2.  Beneficial effect of oral lithium carbonate in the treatment of pancreatic cholera syndrome.

Authors:  S J Pandol; L Y Korman; D M McCarthy; J D Gardner
Journal:  N Engl J Med       Date:  1980-06-19       Impact factor: 91.245

3.  Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome.

Authors:  M Camilleri; A Acosta; I Busciglio; A Boldingh; R B Dyer; A R Zinsmeister; A Lueke; A Gray; L J Donato
Journal:  Aliment Pharmacol Ther       Date:  2015-01-16       Impact factor: 8.171

4.  The use of chlorpromazine in the treatment of cholera and other severe acute watery diarrheal diseases.

Authors:  M R Islam; D A Sack; J Holmgren; P K Bardhan; G H Rabbani
Journal:  Gastroenterology       Date:  1982-06       Impact factor: 22.682

5.  Glucocorticoids and tumor necrosis factor-alpha synergize to induce absorption by the epithelial sodium channel in the colon.

Authors:  Theresa Bergann; Sebastian Zeissig; Anja Fromm; Jan F Richter; Michael Fromm; Joerg-Dieter Schulzke
Journal:  Gastroenterology       Date:  2008-12-10       Impact factor: 22.682

Review 6.  Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis.

Authors:  Mark S Riddle; Sarah Arnold; David R Tribble
Journal:  Clin Infect Dis       Date:  2008-10-15       Impact factor: 9.079

7.  Effect of a bulk-forming cathartic on diarrhea in tube-fed patients.

Authors:  D J Heather; L Howell; M Montana; M Howell; R Hill
Journal:  Heart Lung       Date:  1991-07       Impact factor: 2.210

8.  Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency.

Authors:  M Read; N W Read; D C Barber; H L Duthie
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

9.  Physiologic and pharmacologic effects of glucocorticoids on ion transport across rabbit ileal mucosa in vitro.

Authors:  J H Sellin; M Field
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

10.  Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.

Authors:  Kishore R Iyer; Marek Kunecki; Joseph I Boullata; Ken Fujioka; Francisca Joly; Simon Gabe; Ulrich-Frank Pape; Stéphane M Schneider; María Nuria Virgili Casas; Thomas R Ziegler; Benjamin Li; Nader N Youssef; Palle B Jeppesen
Journal:  JPEN J Parenter Enteral Nutr       Date:  2016-11-23       Impact factor: 4.016

View more
  6 in total

1.  Dual Inhibition of Phosphodiesterase and Ca++ Channels Explains the Medicinal Use of Balanites aegyptiaca (L.) in Hyperactive Gut Disorders.

Authors:  Najeeb Ur Rehman; Mohd Nazam Ansari; Wasim Ahmad; Syed Rizwan Ahamad
Journal:  Plants (Basel)       Date:  2022-04-27

2.  Antifungal activity and antidiarrheal activity via antimotility mechanisms of (-)-fenchone in experimental models.

Authors:  Michelle Liz de Souza Pessoa; Leiliane Macena Oliveira Silva; Maria Elaine Cristina Araruna; Catarina Alves de Lima Serafim; Edvaldo Balbino Alves Júnior; Alessa Oliveira Silva; Matheus Marley Bezerra Pessoa; Hermes Diniz Neto; Edeltrudes de Oliveira Lima; Leônia Maria Batista
Journal:  World J Gastroenterol       Date:  2020-11-21       Impact factor: 5.742

Review 3.  The Role of Purported Mucoprotectants in Dealing with Irritable Bowel Syndrome, Functional Diarrhea, and Other Chronic Diarrheal Disorders in Adults.

Authors:  Carmen Alonso-Cotoner; Mar Abril-Gil; Mercé Albert-Bayo; John-P Ganda Mall; Elba Expósito; Ana M González-Castro; Beatriz Lobo; Javier Santos
Journal:  Adv Ther       Date:  2021-03-18       Impact factor: 3.845

4.  Effects of α2-adrenoceptor stimulation on luminal alkalinisation and net fluid flux in rat duodenum.

Authors:  Olof Nylander; Markus Sjöblom; John Sedin; David Dahlgren
Journal:  PLoS One       Date:  2022-08-25       Impact factor: 3.752

Review 5.  Understanding the Ethnobotany, Chemistry, Pharmacology, and Distribution of Genus Hydnora (Aristolochiaceae).

Authors:  Elijah Mbandi Mkala; Moses Mutuse Mutungi; Elizabeth Syowai Mutinda; Millicent Akinyi Oulo; Vincent Okelo Wanga; Geoffrey Mwachala; Guang-Wan Hu
Journal:  Plants (Basel)       Date:  2021-03-05

Review 6.  [Definition and treatment of superior mesenteric artery revascularization and dissection-associated diarrhea (SMARD syndrome) in Germany].

Authors:  Patrick Téoule; Katharina Tombers; Mohammad Rahbari; Flavius Sandra-Petrescu; Michael Keese; Nuh N Rahbari; Christoph Reißfelder; Felix Rückert
Journal:  Chirurg       Date:  2021-06-08       Impact factor: 0.955

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.